Combined treatment strategy essential to minimize lung sequelae in COVID-19 patients

A combined treatment strategy targeting SARS-CoV-2 symptoms and severe lung tissue injury is essential to minimize lung sequelae- chronic complications resulting from COVID-19 infection, according to a review published this week in Clinical Microbiology Reviews, a journal of the American Society for Microbiology.

Related Keywords

China ,United States ,Tianjin ,Haihe ,Henan ,American ,Huaiyong Chen ,Emily Henderson ,American Society For Microbiology ,Tianjin University ,Tianjin Institute Of Respiratory Diseases ,Tianjin Key Laboratory Of Lung Regenerative Medicine ,Clinical Microbiology Reviews ,American Society ,Tianjin Institute ,Respiratory Diseases ,Tianjin Key Laboratory ,Lung Regenerative Medicine ,Haihe Hospital ,Severe Acute Respiratory Syndrome ,Chronic ,Covid 19 ,Ibrosis ,Hospital ,Laboratory ,Lungs ,Medicine ,Icrobiology ,Mh ,Progenitor Cells ,Espiratory ,Cars ,Ars Cov 2 ,Stem Cells ,Virus ,